Enjoy complimentary customisation on priority with our Enterprise License!
The global market for cancer pain therapeutics is expected to post a healthy market growth rate of more than 9% during the forecast period. The steady growth of this market can be attributed to the launch of new products that specifically treat pain related to cancer.
Technavio’s market research analyst anticipates factors such as the unmet medical needs of patients to drive the market growth during the forecast period. Currently, the drugs that are available for reducing pains associated with cancer have a prolonged duration of action and are characterized by undesirable effects like sedation and respiratory depression. Consequently, this presents an opportunity for the vendors to bring in therapies with fewer side effects and a better efficacy parameter.
Geographically, the Americas are expected to account for more than 47% of the total market share by 2019. In the Americas, the US is considered to be the highest revenue-generating geography due to the recent increase in the incidence of cancer in this region.
Non-steroidal anti-inflammatory drugs are the most commonly used drugs because of their high efficacy and anti-inflammatory action. These drugs block the production of prostaglandins by inhibiting the cyclooxygenase enzyme and, therefore, reduce the pain at the site of injury.
This market is highly fragmented and contains numerous competitive small and large vendors. Large vendors like BioDelivery Sciences and ProStrakan Group dominate this market during the forecast period and constantly compete with each other to gain maximum traction in this market.
Technavio also offers customization on reports based on specific client requirement.
Related reports
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Disease overview
PART 06: Pipeline portfolio
PART 07: Market landscape
PART 08: Market segmentation by drug class
PART 09: Geographical segmentation
PART 10: Market drivers
PART 11: Impact of drivers
PART 12: Market challenges
PART 13: Impact of drivers and challenges
PART 14: Market trends
PART 15: Vendor landscape
PART 16: Vendor landscape
PART 17: Key vendor analysis
PART 18: Appendix
PART 19: Explore Technavio
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.